CTKB vs NOK · rev $92.3M vs P/E 87, $78.04B cap
Cytek Biosciences Inc (CTKB) versus Nokia Corp ADR (NOK) — a side-by-side from cached financials, not a winner call.
Cytek Biosciences Inc (CTKB) is a medical devices company listed on US.
Nokia Corp ADR (NOK) is a communication equipment company listed on NYSE.
Latest reported CTKB revenue for 2026-06-30 was $92.3M. Net income was -$31.0M. CTKB currently screens at market cap $421.8M.
NOK does not have a complete income-statement cache yet.
CTKB currently screens at market cap $421.8M. NOK currently screens at market cap $78.04B and trailing P/E 87.4.
Not investment advice. Open the CTKB and NOK stock pages for the full models.
Not investment advice.